Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Harmony Biosciences Holdings (HRMY) Consolidated Net Income: 2019-2025

Historic Consolidated Net Income for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Sep 2025 value amounting to $50.9 million.

  • Harmony Biosciences Holdings' Consolidated Net Income rose 10.35% to $50.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $157.7 million, marking a year-over-year increase of 44.38%. This contributed to the annual value of $117.5 million for FY2024, which is 1.78% up from last year.
  • As of Q3 2025, Harmony Biosciences Holdings' Consolidated Net Income stood at $50.9 million, which was up 27.88% from $39.8 million recorded in Q2 2025.
  • In the past 5 years, Harmony Biosciences Holdings' Consolidated Net Income registered a high of $87.9 million during Q3 2022, and its lowest value of -$9.6 million during Q3 2021.
  • For the 3-year period, Harmony Biosciences Holdings' Consolidated Net Income averaged around $33.6 million, with its median value being $38.3 million (2024).
  • Examining YoY changes over the last 5 years, Harmony Biosciences Holdings' Consolidated Net Income showed a top increase of 59,688.89% in 2021 and a maximum decrease of 603.93% in 2021.
  • Harmony Biosciences Holdings' Consolidated Net Income (Quarterly) stood at $19.1 million in 2021, then soared by 154.53% to $48.5 million in 2022, then tumbled by 72.81% to $13.2 million in 2023, then surged by 62.84% to $21.5 million in 2024, then grew by 10.35% to $50.9 million in 2025.
  • Its Consolidated Net Income was $50.9 million in Q3 2025, compared to $39.8 million in Q2 2025 and $45.6 million in Q1 2025.